Objective To investigate the spiral CT and ultrasound findings of hepatic adenoma and the value of spiral CT and ultrasound in the diagnosis of hepatic adenoma. Methods A retrospective analysis was performed for the spiral CT and ultrasound findings of 15 patients with pathologically confirmed hepatic adenoma in Langfang Hospital of Traditional Chinese Medicine from July 2009 to December 2015. Results All the 15 patients showed hypoechoic,isoechoic,or hyperechoic ultrasound findings. Seven of these patients had single hepatic adenoma. In the 7 cases,4 had low-density lesions,1 had a slightly low-density lesion,and 2 had equal-density lesions; as for the arterial phase,5 showed obvious enhancement,1 showed moderate enhancement,and 1 showed mild enhancement; as for the portal venous phase and delayed phase,3 showed reduced enhancement,2 had equal-density lesions,and 2 showed gradual enhancement. Eight patients experienced multiple hepatic adenoma with 80 lesions in total. In the 80 lesions,4 lesions( 3 patients) showed a mixed density,40 lesions( 4patients) showed a low density,36 lesions( 4 patients) showed a slightly low density; 8 lesions( 4 patients) showed obvious enhancement in the arterial phase and reduced enhancement in the portal venous phase and delayed phase; 3 lesions( 1 patient) showed obvious enhancement in the arterial phase and an equal density in the portal venous phase and delayed phase; 18 lesions( 2 patients) showed obvious enhancement in the arterial phase and portal venous phase and reduced enhancement in the delayed phase; 49 lesions( 5 patients) showed moderate enhancement in the arterial phase and reduced enhancement in the portal venous phase and delayed phase; 2 lesions( 1 patient)showed no enhancement in any phase. The correct rates of spiral CT in the diagnosis of single hepatic adenoma and multiple hepatic adenomas were 14. 3%( 1 /7) and 87. 5%( 7 /8),respectively. Conclusion Ultrasound can only suggest space-occupying lesions,but cannot analyze the lesions qualitatively; spiral CT with three-phase enhancement scanning has a great value in the diagnosis of hepatic adenoma,especially multiple hepatic adenoma.
[1]LIN H,van den ESSCHERT J,LIU C,et al.Systematic review of hepatocellular adenoma in China and other regions[J].J Gastroenterol Hepatol,2011,26(1):28-35.
|
[2]BASTATI-HUBER N,PTTER-LANG S,BA-SSALAMAH A.Focal nodular hyperplasia and hepatocellular adenoma[J].Radiologe,2015,55(1):18-26.
|
[3]DHINGRA S,FIEL MI.Update on the new classification of hepatic adenomas:clinical,molecular,and pathologic characteristics[J].Arch Pathol Lab Med,2014,138(8):1090-1097.
|
[4]XIA B,YANG XH,GAO JB,et al.Multi-slice spiral CT diagnosis and differential diagnosis of hepatic adenoma[J].J Pract Radiol,2012,28(4):564-566.(in Chinese)夏宾,杨学华,高剑波,等.肝腺瘤多排螺旋CT诊断及鉴别诊断[J].实用放射学杂志,2012,28(4):564-566.
|
[5]GRANT D,FISHER RA,ABECASSIS M,et al.Should the liver transplant criteria for hepatocellular carcinoma be different between Deceased donation and living donation?[J].Liver Transpl,2011,17(Suppl 2):s133-s138.
|
[6] ZHAO J,ZHAO XM,OUYANG H,et al.Imaging characteristics of hepatocellular adenoma compared with patholgic findings[J].Chin J Radiol,2012,46(12):1096-1100.(in Chinese)赵晶,赵心明,欧阳汉,等.肝细胞腺瘤的影像表现与病理结果的对照分析[J].中华放射学杂志,2012,46(12):1096-1100.
|
[7]BIOULAC-SAGE P,BALABAUD C,ZUCMAN-ROSSI J.Subtype classification of hepatocellular adenoma[J].Dig Surg,2010,27(1):39-45.
|
[8]WANG J,WANG XK,YE HY.CT and MRI diagnosis of hepatocellular adenoma[J].Chin J Gen Pract,2012,11(9):645-647.(in Chinese)王佳,王鑫坤,叶慧义.肝细胞腺瘤的CT和MRI影像诊断[J].中华全科医师杂志,2012,11(9):645-647.
|
[9]DAGA BV,SHAH VR,MORE RB.CT scan diagnosis of hepatic adenoma in a case of von Gierke disease[J].Indian J Radiol imaging,2012,22(1):54-57.
|
[10]MOHAJER K,FRYDRYCHOWICZ A,ROBBINS JB,et al.Characterization of hepatic adenoma and focal nodular hyperplasia with gadoxetic acid[J].Magn Reson Imaging,2012,36(3):686-696.
|
[1] | Kexin QIAO, Guiqin ZHOU, Yaxing LIU, Ying FENG, Yao LIU, Bin LI, Xianbo WANG. Clinical features of primary biliary cholangitis patients with negative or positive anti-mitochondrial antibody: A comparative study[J]. Journal of Clinical Hepatology, 2024, 40(9): 1778-1784. doi: 10.12449/JCH240910 |
[2] | Cui NaNa, Wang QiXia. Diagnosis and differential diagnosis of autoimmune hepatitis[J]. Journal of Clinical Hepatology, 2020, 36(4): 724-727. doi: 10.3969/j.issn.1001-5256.2020.04.002 |
[3] | Zhang LiXia, Huang Xu, Sun XiaoJie, Zhang Ying, Lu ShaSha, Shi XiaoDong, Ji HuiFan, Guo XiaoLin. A case of antimitochondrial antibody-negative primary biliary cholangitis[J]. Journal of Clinical Hepatology, 2019, 35(1): 179-181. doi: 10.3969/j.issn.1001-5256.2019.01.038 |
[4] | Han Ying, Chen Jie, Dan Jing, Liu YanMin, Zhang XiaoDan, Ren MeiXin, Du XiaoFei, Bian XinQu, Liu Dan, Huang YunLi, Huang ChunYang, Liao HuiYu. Value of fumarate hydratase antibody in differential diagnosis of autoimmune hepatitis and drug-induced liver injury[J]. Journal of Clinical Hepatology, 2019, 35(6): 1326-1329. doi: 10.3969/j.issn.1001-5256.2019.06.029 |
[5] | Liu HongLi, Yang YongFeng. Clinical and pathological features of primary biliary cholangitis with negative anti-mitochondrial antibody[J]. Journal of Clinical Hepatology, 2019, 35(3): 677-680. doi: 10.3969/j.issn.1001-5256.2019.03.051 |
[6] | Bian ZhaoLian, Shao JianGuo, Ma Xiong. Differential diagnosis of drug-induced liver injury and autoimmune hepatitis and related therapeutic strategies[J]. Journal of Clinical Hepatology, 2018, 34(6): 1156-1159. doi: 10.3969/j.issn.1001-5256.2018.06.003 |
[7] | Luo WenPing, Ma Hong, Zhao XinYan. Pathological features of hepatic vascular diseases and key points in differential diagnosis[J]. Journal of Clinical Hepatology, 2018, 34(11): 2289-2294. doi: 10.3969/j.issn.1001-5256.2018.11.005 |
[8] | Jiang LiLin, Shen JianBo, Tang Hong, Lu ZhongHua. Pathological differential diagnosis of inflammatory liver injury[J]. Journal of Clinical Hepatology, 2018, 34(11): 2278-2282. doi: 10.3969/j.issn.1001-5256.2018.11.003 |
[9] | Du XiaoFeng, Ma ZhouPeng, Lin GuanSheng, He Hui, Tang YaRong, Wu JianMing. CT diagnosis and differentiation of nodular/mass-type hepatic lymphoma[J]. Journal of Clinical Hepatology, 2017, 33(8): 1492-1496. doi: 10.3969/j.issn.1001-5256.2017.08.016 |
[10] | Li Jing, Tang ShaoShan, Yu HongWei. Value of contrast-enhanced ultrasound in differential diagnosis of single metastatic liver cancer and solitary necrotic nodule of the liver[J]. Journal of Clinical Hepatology, 2016, 32(7): 1338-1341. doi: 10.3969/j.issn.1001-5256.2016.07.025 |
[11] | Wang Sui, Wang JiangBin. The diagnosis and treatment of primary biliary cirrhosis[J]. Journal of Clinical Hepatology, 2015, 31(10): 1605-1607. doi: 10.3969/j.issn.1001-5256.2015.10.010 |
[12] | Chinese Society of Hepatology, Chinese Medical Association; Chinese Society of Gastroenterology, Chinese Medical Association; Chinese Society of Infectious Diseases, Chinese Medical Association. Consensus on the diagnosis and management of primary biliary cirrhosis (cholangitis)(2015)[J]. Journal of Clinical Hepatology, 2015, 31(12): 1980-1988. doi: 10.3969/j.issn.1001-5256.2015.12.004 |
[13] | Zhang AnYuan, Chen Hao, Zhao Peng, Gong JianPing. Differential diagnosis of autoimmune pancreatitis from pancreatic cancer[J]. Journal of Clinical Hepatology, 2015, 31(5): 783-786. doi: 10.3969/j.issn.1001-5256.2015.05.038 |
[14] | Guo Jing, Xu LingFen, Sun Mei. Differential diagnosis of biliary atresia and intrahepatic cholestasis in children[J]. Journal of Clinical Hepatology, 2015, 31(8): 1252-1256. doi: 10.3969/j.issn.1001-5256.2015.08.017 |
[15] | Cao ZhangChun. Significance of combined analysis of autoantibodies in diagnosis of primary biliary cirrhosis[J]. Journal of Clinical Hepatology, 2015, 31(2): 178-180. doi: 10.3969/j.issn.1001-5256.2015.02.008 |
[16] | Li YinPing, Niu JunQi. Significance of serum anti-gp210 antibody detection in diagnosis of primary biliary cirrhosis[J]. Journal of Clinical Hepatology, 2014, 30(5): 466-468. doi: 10.3969/j.issn.1001-5256.2014.05.023 |
[17] | Zhao DanTong, Liao HuiYu, Liu YanMin, Huang ChunYang, Zhang HaiPing, Sun LiMei, Ma YinXue, Zhao Yan, Yan HuiPing. ROC analysis of prognostic factors in Chinese patients with primary biliary cirrhosis[J]. Journal of Clinical Hepatology, 2014, 30(1): 62-66. doi: 10.3969/j.issn.1001-5256.2014.01.017 |
[18] | Li Bing, Shao Qing, Niu XiaoXia, Zhang Jian, Chen GuoFeng. Clinical features and diagnosis of autoimmune hepatitis-primary biliary cirrhosis overlap syndrome[J]. Journal of Clinical Hepatology, 2014, 30(5): 413-416. doi: 10.3969/j.issn.1001-5256.2014.05.007 |
[19] | Zhang Li, Bai ShiShan. Research progress on laboratory diagnosis of primary biliary cirrhosis[J]. Journal of Clinical Hepatology, 2011, 27(10): 1109-1111+1120. |